Molecular interactions between inhaled anesthetics and proteins

Pharmacological Reviews

Volumn 49, Issue 4, 1997, Pages 343-367

  Eckenhoff, Roderic G ^a,b   Johansson, Jonas S ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BARBITURIC ACID DERIVATIVE; CHLOROFORM; DESFLURANE; DRUG BINDING PROTEIN; ETHER; HALOTHANE; HEMOGLOBIN; INHALATION ANESTHETIC AGENT; ISOFLURANE; METHANOL; METHOXYFLURANE; MYOGLOBIN; OPIATE; PROPOFOL; SERUM ALBUMIN;

CRYSTALLOGRAPHY; DRUG BINDING SITE; DRUG PROTEIN BINDING; EQUILIBRIUM CONSTANT; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LIGAND BINDING; MOLECULAR INTERACTION; NONHUMAN; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; REVIEW; SPECTROSCOPY; THERMODYNAMICS;

ANESTHETICS, INHALATION; BINDING SITES; KINETICS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEINS; THERMODYNAMICS;

EID: 0031459734     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (230)

1. ABADJI, V. C. RAINES, D. E., DALTON, L. A., AND MILLER, K. W.; Lipid-protein interactions and protein dynamics in vesicles containing the nicotinic acetylcholine receptor: a study with cthanol. Biochim. Biophys. Acta 1194: 215-34, 1994.
2. ABADJI, V. C., RAINES, D. E., WATTS, A., AND MILLER, K. W.; The effect of general anesthetics on the dynamics of phosphatidylcholine-acetylcholine receptor interactions in reconstituted vesicles. Biochim. Biophys. Acta 1147: 143-153, 1093.
3. ABRAHAM, M. H., LIEB, W. R., AND FRANKS, N. P.; Role of hydrogen bonding in general anesthesia. J. Phurm. Sci. 80: 719-724, 1991.
4. ABRAHAM, M. H., WHITING, G. S., FUCHS, H., AND CHAMBERS, E. J.; Thermodynamics of solute transfer from water to hexadecane. J. Chem. Soc. Perkin Trans. 2: 291-300, 1990.
5. ADEY, G,. WARDLEY-SMITH, H., AND WHITE, D.; Mechanism of inhibition of bacterial luciferase by anaesthetics. Life Sci. 17: 1849-1854, 1975.
6. 1, interface in haemoglobin using Fourier transform infrared spectroscopy. Nature (Lond.) 252: 736-738, 1974.
7. ALIFIMOFF, J. K., FlRESTONE, L. L., AND MILLER. K. W.; Anaesthetic potencies of primary alkanols: implications for the molecular dimensions of the an aesthetic site. Br. J. Pharmacol. 96: 9-16, 1989.
8. ARONSTAM, R. S., AND DENNISON, H. L.; Anesthetic effects on muscarinic signal transduction. Int. Anesthesiol. Clin. 27: 265-272, 1989.
9. BARKER, R. W., BROWN, F. F., DRAKE., R., HALSEY, M. J., AND RICHARDS, R. E.; Nuclear magnetic resonance studies of anaesthetic interactions with haemoglobin. Br. J. Anaesth. 47: 25-29, 1975.
10. BEECHEM, J. M., AND BRAND, L.; Time-resolved fluorescence of proteins. Ann. Rev. Biochem. 54: 43-71, 1985.
11. BEN-NAIM, A.; Hydrophobic Interactions, p. 311, Plenum Press, New York, 1980.
12. BERNARD, C. M.; Leçons sur les Anesthésiques et sur L'Asphyxie, p. 404, Libraire J.- B. Ballière et fils, Paris, 1875.
13. BIANCHET, M. A., BAINS, G., PELOSI, P., PEVSNER, J., SNYDER, S. H., MONACO, H. L., AND AMZEL, L. M.; The three-dimensional structure of bovine odorant binding protein and its mechanism of odor recognition. Nat. Struct. Biol. 3: 934-939, 1996.
14. BIGELOW, D. J., AND THOMAS, D. D.; Rotational dynamics of lipid and the CaATPase in sarcoplasmic reticulum. J. Biol. Chem. 262: 13449-13456, 1987.
15. BOUCHET, M.-J., AND GOELDNER, M.; Photochemical labeling: can photoaffinity labeling be differentiated from site-directed photochemical coupling? Photochem. Photobiol. 65: 195-200, 1997.
16. BROCKERHOFF, H., BROCKERHOFF, S., AND Box, L. L.; Mechanism of anesthesia: the potency of four derivatives of octane corresponds to their hydrogen bonding capacity. Lipids 21: 405-408, 1986.
17. BROOKS, C. L., KARPLUS, M., AND PETTITT, B. M.; Proteins: a theoretical perspective of dynamics, structure and thermodynamics, p. 259, John Wiley & Sons, New York, 1988.
18. BROWN, F. F., HALSEY, M. J., AND RICHARDS, R. E.; Halothane interactions with haemoglobin. Proc. R. Soc. Lond. B Biol. Sci, 193: 387-411, 1976.
19. BUCKLE, A. M., CRAMER, P., AND FERSHT, A. R.; Structural and energetic responses to cavity-creating mutations in Hydrophobic cores: observation of a buried water molecule and the hydrophilic nature of such hydrophobic cavities. Biochemistry 35: 4298-4305, 1996.
20. BURLEY, S. K., AND PETSKO, G. A.; Weakly polar interactions in proteins. Adv. Protein Chem. 39: 125-189, 1988.
21. CALCIANO, L. J., ESCOBAR, W. A., MILLHAUSER, G. L., MIICK, S. M., RUBALOFF, J., TODD, A. P., AND FINK, A. L.; Side-chain mobility of the β-lactamase A state probed by electron spin resonance spectroseopy. Biochemistry 32: 5644-5649, 1993.
22. CAMPBELL, D. B., AND NASH, H. A.; Use of Drosophila mutants to distinguish among volatile general anesthetics. Proc. Natl. Acad. Sci. USA 91: 2135-2139, 1994.
23. CANTOR, R. S.; The lateral pressure profile in membranes: a physical mechanism of general anesthesia. Biochemistry 36: 2339-2344, 1997.
24. CARROLL, J. A., SHAW, J. S., AND WICKENDEN, A. D.; The physiological relevance of low agonist affinity binding at opiod μ-receptors. Br. J. Pharmacol. 94: 625-631, 1988.
25. CARTER, D. C., AND HO, J. X.; Structure of serum albumin. Adv. Protein Chem. 45: 153-203, 1994.
26. CHIOU, J-S., TATARA, T., SAWAMURA, S., KAMINOH, Y., KAMAYA, H., SHIBATA, A., AND UEDA, I.; The α-helix to β-sheet transition in poly(L-lysine): effects of anesthetics and high pressure. Biochim. Biophys. Acta 1119: 211-217, 1992.
27. CHIOU, J-S., AND UEDA, I.; Ethanol unfolds firefly luciferase while competitive inhibitors antagonize unfolding: DSC and FTIR analyses. J. Pharm. Biomed. Anal. 12: 969-975, 1994.
28. CHIU, W.; What does electron cryomicruscopy provide that X-ray crystallography and NMR spectroseopy cannot? Annu. Rev. Biophys. Biomol. Struct. 22: 233-255, 1993.
29. CLORE, G. M., AND GRONENBORN, A. M.; Two-, three-, and four-dimensional NMR methods for obtaining larger and more precise three-dimensional structures of proteins in solution. Annu. Rev. Biophys. Biophys. Chem. 20: 29-63, 1991.
30. COBB, C. E., JULIAO, S., BALASUBRAMANIAN, K., STAROS, J. V., AND BETH, A. H.; Effects of diethyl ether on membrane lipid ordering and on rotational dynamics of the anion exchange protein in intact human erythrocytes: correlations with anion exchange function. Biochemistry 29: 10799-10806, 1990.
31. COOPER, J. R., BLOOM, F. E., AND ROTH, K. H.; The Biochemical Basis of Neuropharmacology, 4th Ed., p. 73, Oxford University Press, New York, 1982.
32. CURATOLA, G., LENAZ, G., AND ZOLESE, G.; Anesthetic-membrane interactions: effects on membrane structure and function. In Drug and Anesthetic Effects on Membrane Structure and Function, ed. by R, C. Aloia, C. C. Curtain, and L. M. Gordon, pp. 35-70, Wilcy-Liss, New York, 1991.
33. DAGGETT, V., AND LEVITT, M.; Realistic simulations of native-protein dynamics in solution and beyond. Annu. Rev. Biophys. Biomol. Struct. 22: 353-380, 1993.
34. 19F NMR to probe protein structure and conformational changes, Annu. Rev. Biophys. Biomol. Struct. 29: 163-195, 1996.
35. DEISENHOFER, J., AND MICHEL, H.; High-resolution structures of photosynthetic reaction centers. Annu. Rev. Biophys. Biophys. Chem. 20: 247-266, 1991.
36. DELOREY, T. M., AND BROWN G. B.; γ-Aminobutyric acid α-receptor pharmacology in rat cerebral cortical synaptoneurosomes. J. Neurochem. 58: 2162-2169, 1992.
37. DICKINSON, R., FRANKS, N. P., AND LIEB, W. R.; Thermodynamics of anesthetic/ protein interactions. Biophys. J. 64: 1264-1271, 1993.
38. DICRINSON, R., FRANKS, N. P., AND LIEB, W. R.; Can the stereoselective effects of the anesthetic isoflurane be accounted for by lipid solubility? Biophys. J. 66: 2019-2023, 1994.
39. DILGER, J. P., AND VIDAL, A. M.; Cooperative interactions between general anesthetics and QX-222 within the pore of the acetylcholine receptor ion channel. Mol. Pharmacol. 45: 169-175, 1994.
40. DIPAOLO, T., AND SANDORFY, C.; Hydrogen bond breaking potency of fluorocarbon anesthetics. J. Med. Chem. 17: 809-814, 1974a.
41. DIPAOLO, T., AND SANDORFY, C.; Fluorocarbon anaesthetics break hydrogen bonds. Nature (Lond.) 252: 471-472, 1974b.
42. DONG, A., AND CAUGHEY, W. S.; Infrared methods for study of hemoglobin reactions and structures. Methods Enzymol. 232: 139-175, 1994.
43. DONG, A., HUANG, P., ZHAO, X. J., SAMPATH, V., AND CAUGHEY, W. S.; Characterization of sites occupied by the anesthetic nitrous oxide within proteins by infrared spcctroscupy. J. Biol. Chem. 269: 23911-23917, 1994.
44. DORSET, D. L.; Structural Electron Crystallography, p. 425, Plenum Press, New York, 1995.
45. 19F-NMR study Proc Natl. Acad. Sci. USA 90: 6478-6482, 1993.
46. 2) method for characterizing anesthetic binding to proteins: analysis of isoflurane binding to albumin. Biochemistry 31: 7069-7076, 1992.
47. ECKENHOFF, R. G.; Amino acid resolution of halothane binding sites in serum albumin. J. Biol. Chem. 271: 15321-15526, 1996a.
48. ECKENHOFF, R. G.; An inhalational anesthetic binding domain in the nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. USA 93: 2807-2810. 1996b.
49. ECKENHOFF, R. G., AND FAGAN, D.; Inhalation anaesthetic competition at high-affinity cocaine binding sites in rat brain synaptosomes. Br. J. Anaeasth 73: 820-825, 1994.
50. ECKENHOFF, R. G., AND SHUMAN, H.; Halothane binding to soluble proteins determined by photoaffinity labeling. Anesthesiology 79: 96-106, 1993.
51. EFTINK, M. R.; Fluorescence quenching: theory and applications. In Topics in Fluorescence Spectroscopy, Principles, ed. by J. R. Lakowicz, vol. 2, pp. 53-126, Plenum Press, New York, 1991.
52. EFTINK, M. R., AND GHIRON, C. A.; Fluorescence quenching studies with proteins. Anal. Biochem. 114: 199-227, 1981.
53. EGER, E. I., KOBLIN, D. D., LASTER. M. J., SCHURIG, V., JUZA, M., IONESCU, P., AND GONG, D.; Minimum alveolar anesthetic concentration values for the enantiomers of isoflurune differ minimally. Anesth. Analg. 85: 188-192, 1997.
54. EGER, E. I., LIU, J., KOBLIN, D. D., LASTER, M. J., TAHERI, S., HALSKY, M. J., IONESCU, P., CHORTKOFF, B. S., AND HULICKY, T.; Molecular properties of the "ideal" inhaled anesthetic: studies of fluorinated methanes, ethanes, propanes, and butanes. Anesth. Analg. 79: 245-251, 1994.
55. EIGEN, M., AND HAMMES, G. G.; Elementary steps in enzyme reactions. Adv. Methods Enzymol. 25: 1-38, 1963.
56. EISENBERG, D., AND HILI, C. P.; Protein crystallography; more surprises ahead. Trends Biochem. Sci. 14: 260-264, 1989.
57. EL-MAGHRABI, E. A., AND ECKENHOFF, R. G.; Inhibition of dopamine transport in rat brain synaptosomes by volatile anesthetics. Anesthesiology 78: 750-756, 1993.
58. EL-MAGHRABI, E. A., ECKENHOFF, R. G., AND SHUMAN, H.; Saturable binding of halothane to rat brain synaptosomes. Proc. Natl. Acad. Sci. USA 89: 4329-4332, 1992.
59. ENGLANDER, S. W., AND ENGLANDER, J. J.; Structure and energy change in hemoglobin by hydrogen exchange labeling. Methods Enzymol. 232: 26-42, 1994.
60. ERIKSSON, A. E., BAASF, W. A., WOZNIAK, J. A., AND MATTHEWS, B. W.; A cavity-containing mutant of T4 lysozyme is stabilized by buried benzene. Nature (Lond.) 355: 371-373, 1992a.
61. ERIKSSON, A. E., BAASE, W. A., ZHANG, X-J., HEINZ, D. W., BLABER, M., BALDWIN, E. P., AND MATTHEWS, B. W.; Response of a protein structure to cavity-creating mutations and its relation to the Hydrophobic effect. Science (Wash. DC) 255: 178-183, 1992b.
62. ERNST, J. A., CLUBB, R. T., ZHOU, H-X., GRONENBORN, A., AND CLORE, G. M.; Demonstration of positionally disordered water within a protein HydrophobiC cavity by NMR. Science (Wash. DC) 267: 1813-1817. 1995.
63. ERNST, M., AND ERNST, R. R.; Heteronuclear dipolar cross-correlated cross relaxation for the investigation of side-chain motions. J. Magn. Reson. A 110: 202-213. 1994.
64. ERNST, R. H.; Nuclear magnetic resonance Fourier transform spectroscopy. Angew. Chem. Int. Ed. Eng. 31: 805-823, 1992.
65. ERNST, R. R.; Nuclear magnetic resonance Fourier transform spectroscopy. Bull. Magn. Reson. 16: 5-32, 1994.
66. 19F-NMR spectroscopy and photoaffinity labeling. Prog. Anesth. Mechanism. 3: 151-157, 1995.
67. EWING, G. J., AND MAESTAS, S.; The thermodynamics of absorption of xenon by myoglobin. J. Phys. Chem. 74: 2341-2344. 1970.
68. FFRGUSON, J.; The use of chemical potentials as indices of toxicity. Proc. R. Soc. lond. B Biol. Sci. 127: 387-404, 1939.
69. FERSHT, A. R., SHI, J-P., KNILL-JONES, J., LOWE, D. M., WILKINSON A. J., BLOW, D. M., BRICK, P., CARTER, P., WAYK, M, M. Y., AND WINTER, G.; Hydrogen bonding and biological specificity analysed by protein engineering. Nature (Lond.) 314: 235-238, 1985.
70. FINN, B. E., EVENÄS, J., DRAKENBERG, T., WALTHO, J. P., THULIN, E., AND FORSÉN, S.; Calcium-induced structural changes and domain autonomy in calmodulin. Nat. Struct. Biol. 2: 777-783, 1995.
71. FIRESTONE, L. L., ALIFIMOFF, J. K., AND MILLER, K. W.; Does general anesthetic-induced desensitization of the Torpedo acetylcholine receptor correlation with lipid disordering? Mol. Pharmacol. 48: 508-515, 1994.
72. FISHER, H. F., AND SINGH, N.; Calorimetric methods for interpreting proteinligand interactions. Methods Enzymol. 259: 194-221, 1995.
73. FORMAN, S. A., MILLER, K. W., AND YELLEN, G.; A discrete site for general anesthetics on a postsynaptic receptor, Mol. Pharmacol. 48: 574-581, 1995.
74. FRANKS, N, P., AND LIEB, W. K.; Do general anaesthetics act by competitive binding to specific receptors? Nature (Lond.) 310: 599-601, 1984.
75. FRANKS, N. P., AND LIEB, W. K.; Molecular und cellular mechansims of general anaesthesia. Nature (Lond.) 387: 607-614, 1994.
76. FRANKS, N. P., AND LIEB, W. R.; Selective actions of volatile general anaesthetics at molecular and cellular levels. Br. J. Anuesth. 71: 65-76, 1993.
77. FRANKS, N. P., AND LIEB, W. K.; Stereospecific effects of inhalational general anesthetic optical isomers on nerve ion channels. Science (Wash. DC) 254: 427-430, 1991.
78. PRANKS, N. P., AND LIEB, W, R.; Temperature dependence of the potency of volatile general anesthetics: implications for in vitro experiments. Anesthesiology 84: 716-720, 1996.
79. FRANKS, N. P., AND LIEB, W. K.; Where do general anesthetics act? Nature (Lond.) 274: 3139 -342, 1978.
80. FRASER, D. M., LOURO, S. R. W., HORVATH, L. I., MILLER, K. W., AND WATTS, A.; A study of the effect of general anesthetics on lipid-proteln interactions in acetyleholine receptor enriched membranes from Torpedo nibiliana using nitroxide spin-labels. Biochemistry 29: 2664-2669, 1990.
81. FRAUENFELDER, H., SLIGAR, S. G., AND WOLYNES, P. G.; The energy Iandsenpes and motions of proteins. Science (Wash. DC) 254: 1598-1603, 1991.
82. GETHING, M. J., AND SAMBROOK, J.; Protein folding in the cell. Nature (Lond.) 358: 33-45, 1992.
83. GIBNEY, B. R., JOHANSSON, J. S., RABANAL, F., SKALICKY, J. J., WAND, A. J., AND DUTTON, P. L.; Global topology & stability and local structure & dynamics in a synthetic spin-labeled four-helix bundle protein, Biochemistry 36: 2798-2806, 1997a.
84. GIBNEY, B. R., RABANAL, F., SKALICKY, J. J., WAND, A. J., AND DUTTON, P. L.; Design of a unique protein scaffold for maquettes. J. Am. Chem. Soc. 119: 2323-2324, 1997b.
85. GORGA, J. C., HAZZARD, J. H., AND CAUGHEY, W. S.; Determination of anesthetic molecule environments by infrared spoctroscopy. Arch. Bioehem. Biophys. 240: 734-746, 1985.
86. GRAY, H. B.; Chemical Bonds; An Introduction to Atomic and Molecular Structure, p. 232, University Science Books, Mill Valley, CA, 1994.
87. GREENBLATT, D. J., ALLEN, M. D., HARMATZ, J. S., AND SHADER, R. I.; Diazepam disposition determinants. Clin. Pharmacol. Ther. 27: 301-312, 1980.
88. 0 derivatives of cortisol. corticostoronc. and progesterone as unsubstituted photoreagents. Biochemistry 33: 8969-8981, 1994.
89. GRUNER, S. M., AND SHYAMSUNDER, E.; Is the mechanism of general anesthesia related to lipid membrane spontaneous curvature? Ann. N. Y. Acnd. Sci. 625: 685-697, 1991.
90. GURSKY, O., FONTANO, E., BHYRAVBHATLA, B., AND CASPAR, D. L. D.; Stereospecific dihaloalkane binding in a pH-sennitive cavity in cubic insulin crystals. Proc. Natl. Acad. Sci. USA 91: 12388-12392, 1994.
91. GUTFRECND, H.; Reflections on the kinetics of substrate binding. Biophys. Chem 26: 117-121, 1987.
92. HAISEY, M. J.; Molecular interactions of anaesthetics with biological membranes. Gen. Pharmacol. 23: 1013-1016, 1992.
93. MANSCH, C., VITTORIA, A., SHIPO, C., AND JOW, P. Y. C.; Partition coefficients and the structure-activity relationship of the anesthetic gases. J. Med. Chem 18: 546-548, 1975.
94. HARRIS, B, MOODY, E., AND SKOLNICK, P.; Isoflurane anesthesia is stereoselec tive. Eur. J. Pharmacol. 217: 217-216, 1992a.
95. HARRIS, J. W., JONES, J. P., MARTIN, J. L., LAROSA, A. C., OLSON, M. J., POHL., L. R., AND ANDERS, M. W.; Pentahaloethane-based chlorofluorocarbon substituies and halothane; correlation of in vivo hepatic protein trifluoroucetylation and urinary trifluoroacetic acid excretion with calculated enthalpies of activation. Chem. Res. Toxicol. 5: 720-725, 1992b.
96. HARRIS, R. A., MIHIC, S. J., DHDY-MAYFIELD, J. E., AND, MACHU, T. K.; Actions of anesthetics on ligand-gated ion channels: role of receptor subunit composition. FASEB J. 9: 1454-1462, 1995.
97. HARVEY, K. N.; The effort of certain organic and inorganic substances upon light production by luminous bacteria. Biol. Bull. 29: 308-311, 1915.
98. HAZZARD, J. H., GORGA, J. C., AND GAUGHEY, W. S.; Determination of anesthetic molecule environments by infrared spectroscopy. Arch. Riochem. Biophys. 240: 747-756, 1985.
99. HE, X. M., AND CARTER, D. C.; Atomic structure and chemistry of human serum albumin. Nature (Lond.) 358: 209-215, 1992.
100. HENDERSON, R., BALDWIN, J. M., CESKA, T. A., ZEMLIN, F., BECKMANN, E., AND DOWNING, K. H.; Model of the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. J. Mol. Biol. 213: 899-929, 1990.
101. HUANG, P., BERTACCINI, E., AND LOEW, G. H.: Molecular dynamics simulation of anesthetic-phospholipid bilayer interactions. J. Biomol. Struct. Dyn. 12: 725-754, 1995.
102. HUBBARD, S. J., AND ARGOS, P.; Cavities and packing at protein interfaces. Protein Sci. 3: 2194-2206, 1994.
103. HUBBARD, S. J., GROSS. K-H., AND ARGOS, P.; Intramolecular cavities in globular proteins. Protein Eng. 7: 613-626, 1994.
104. IWATA, S., OSTERMEIER, G., LUDWIG, B., AND MICHEL, H.; Structure at 2,8 A resolution of cytochrome c oxidase from Paracocus denitrifocam. Nuture (Lond.) 376: 660-669, 1995.
105. JAKOBY, M. G., COVEY, D. F., AND CISTOLA, D. P.; Localization of tolbutamide binding sites on human serum albumin using titration calorimetry and heteronuclear 2-D NMR. Biochemistry 34: 8780-8787, 1995.
106. JAMESON, D. M., AND SAWYER, W. H.; Fluorescence anisotropy applied to biomolecular interactions. Methods Enzymol. 246: 283-300, 1995.
107. ARDETZKY, O.; Protein dynamics and conformational transitions in allosteric proteins. Prog, Biophys. Mol. Biol. 65: 171-219, 1996.
108. JOHANSSON, J. S., ECKENHOFF, R. G., AND DUTTON, P. L.; Binding of halothane to serum albumin demonstrated using tryptophan fluorescence. Anesthesiology 83: 316 -324, 1995a.
109. JOHANSSON, J. S., ECKENHOFF, R. G., AND DUTTON P.L.; Reply to Eger and Koblin: binding of halothane to serum albumin - relevance to theories of narcosis, Anesthesiology 83: 1385, 1995b.
110. JOHANSSON, J. S.; Binding of the volatile anesthetic chloroform to albumin demonstrated using tryptophan fluorescence quenching. J. Biol. Chem. 272: 17961-17965, 1997.
111. JOHANSSON, J. S., AND ECKENHOFF, R. G.; Minimum structural requirement for an inhalntional anesthetic binding site on a protein target. Biochim. Biophys. Acta 1290: 63-68, 1996.
112. JOHANSSON, J. H., GIBNEY, B. K., RABANAL, F., AND DUTTON, P. L.; Use of a synthetic four-α-helix bundle scaffold to characterize the structural features of a volatile anesthetic binding site. Biophys. J. 72: A417, 1997.
113. JOHANSSON, J. S., RABANAL, F., AND DUTTON, P. L.; Binding of the volatile unesthetic halothane to the hydrophobic core of a tetra-α-helix bundle protein. J. Pharmacol. Kxp. Ther. 279: 56-61, 1996.
114. JORGENSEN, K., IPSEN, J. H., MOURITSEN, O. G., AND ZUCKERMANN, M. J.; The effect of anaesthetics on the dynamic heterogeneity of lipid membranes, Chem. Phys. Lipids 69: 205-216, 1993.
115. KARON, B. S., GEDDIS, L. M., KUTOHAI, M., AND THOMAS, D. D.; Anesthetics alter the physical and functional properties of the Ca-ATPase in cardiac sarcoplasmic reticulum. Biophys. J. 68: 936-945, 1995.
116. KARON, B. S., AND THOMAS, D. D.; Molecular mechanism of Ca-ATPase activation by halothane in surcoplusmic roticulum. Biochemistry 32: 7503-7511, 1993.
117. KARPLUS, M., AND PETSKO, G. A.; Molecular dynamics simulations in biology Nature (Lond.) 347: 631-639, 1990.
118. KIENKER, P. K., DEGRADO, W. F., AND LEAR, J. D.; A helical-dipolE model describus tho single-channel current rectification of an uncharged peplide ion channel. Proc. NATl. Acad. SCi. USA 91: 4859-4863, 1994.
119. KLEEREKOPER, Q., HOWARTH, J. W., GUO, X., SOLARO, R. J., AND ROSEVEAR, P. R.; Cardiac troponin I induced conformutional changes in cardiac troponin C as monitored by NMK using site-directed spin and isotope labeling. Biochemistry 34: 13343-13352, 1995.
120. KLEYWEGT, G. J., AND JONES, T. A.; Where freedom is given, liberties are taken. Structure 3: 535-540, 1995.
121. KLEYWEGT, G. J., HOIER, H., AND JONES, T. A.; A re-evaluation of the crystal structure of chloramuconate cycloisomenise. Acta. Crystallogr, D52: 858-863, 1996.
122. 2+-ATPase as a target for volatile anesthetics. Adv. Pharmacol. 31: 313- 322, 1994.
123. KOSTERLITZ, H. W., AND WATERFIELD, A. A.; In vitro models in the study of structure-activity relationships of narcotic analgesics. Ann. Rev. Pharmacol, 15: 29-47, 1975.
124. KURUMBAIL, R.G., STEVENS, A. M., GIERSE, J, K., MCDONALD, J. J., STEGEMAN, R. A., PAK, J. Y., GILDEHAUS, D., MIYASHIRO, J. M., PENNING, T. D., SEIBERT, K., ISAKSON, P. C., AND STALLINGS, W. C.; Structural basis fur selective inhibition of cYclooxygenase-2 by anti- inflammatory agents. Nature (Lond.) 384: 644-648, 1996.
125. LAKOWICZ, J. R.; Principles of Fluorescence Spectroscopy, p. 496, Plenum Publishing Corporation, New York, NY. 1983.
126. LASKOWSKI, R. A., LUSCOMBE, N. M., SWINDELLS, M. B., AND THORNTON, J. M.; Protein clefts in molecular recognition and function. Protein Sci. 5: 2438-2452, 1996.
127. LAZARIDIS, T., ARCHONTIS, G., AND KARPLUS, M.; Enthalpic contribution to protein stability: insights from atom-based calculations and statistical mechanics. Adv. Protein Chem. 47: 231-306, 1995.
128. LEAR, J. D., WASSERMAN, Z. H., AND DEGRADO, W. F.; Synthetic amphiphilic peptide models for protein ion channels. Science (Wash DC) 240: 1177-1181, 1988.
129. LEMMON, M. A., AND ENCELMAN, D. M.; Specificity and promiscuity in membrane helix interactions, Q. Rev. Biophys, 27: 157-218, 1994.
130. LEONARD, R. J., CHARNET, P., LABARCA, C., VOGELAAH, N. J., CZYZYK, L., GOUIN, A., DAVIDSON, N., AND LESTER, H. A.; Reverse pharmacology of the nicotinic acetylcholine receptor. Ann. N. Y. Acad. Sci. 625: 588-599, 1991.
131. LEVITT, M., AND PERUTZ, M. K.; Aromatic rings act as hydrogen bond acceptors. J. Mol. Biol. 201: 751-754, 1988.
132. LEWIS, M., CHANG, G., NORTON, N. C., KERCHER, M. A., PACK, H. C., SCHUMACHER, M. A., BRENNAN, R. G., AND LU, P.; Crystal structure of the lactose operon repressor and its complexes with DNA and inducer. Science (Wash.) 271: 1247-1254, 1996.
133. LIKHTENSHTKIN, G. L.: Biophysical Labeling Methods in Molecular Biology, p. 305, Cambridge University Press, Cambridge, 1993.
134. LIM, W. A., HODEL, A., SAUER, R. T., AND RICHARDS, F. M.: The crystal structure of a mutant protein with altered hut improved Hydrophobic core packing. Proc. Nail. Acad. Sci. USA 91: 423-427, 1994.
135. LlNDEMAN, J., AND LOVINS. R. E.; The mass spectral analysis of covalontly labeled amino acid methylthiohydanloin derivatives derived from affinity. labeled proteins. Anul. Biochem. 75: 682-685, 1976.
136. LIPNICK, R. L.; Charles Ernest Overton: narcosis studies and a contribution to general pharmacology. Trends I'harmacol. Sci. 7: 161-164, 1986.
137. LIPNICK, R. L.; Hans Horst Meyer and the lipoid theory of narcosis. Trends pharmacol. Sci. 10: 265 -269, 1989.
138. LOH. S. N., KAY. M. S., AND BALDWIN, H. L.; Structure and stability of A second molten globule intermediate in the apomyoglobin folding pathway. Proc. Null. Acad. Sci. USA 92: 5446 -5450, 1995.
139. 3H](-)-nicotine binding in rat cortex. Neuropharmacology 32: 847-853, 1993.
140. LYSKO, G. S., ROBINSON, J. L., CASTO, R., AND FERRONE, R. A.; The stereospccific effects of isoflurane isomers in vivo. Eur. J. Pharmacol. 263: 25-29. 1994.
141. MAGNAN, J., PATERSON, S. J., TAVANI, A., AND KOSTERLITZ, H. W.; The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. Naunyn Schmiedeberg's Arch. Pharmacol. 319: 197-205, 1982.
142. MAKHATADZE, G. I., AND PRIVALOV, P. L.; Energetics of protein structure. Adv. Protein Chem. 47: 307-425, 1995.
143. MÄNTELE, W.; Reaction-induced infrared difference spectroscopy for the study of protein function and reaction mechanisms. Trends Biochem. Sci. 18: 197-202, 1993.
144. MARTIN, D. C., ADAMS, R. J., AND INTRONA, R. P. S. I.; Halothanc inhibits 5-hydroxytryptamine uptake bv synaptosomes from rat brain. Neuropharmacology 29: 9-16, 1990a.
145. MARTIN, D. C., INTRONA, R. P., AND ARONSTAM, R. S.; Inhibition of neuronal 5-HT uptake by ketamine, but not halothane, involves disruption of substrate recognition by the transporter. Neurosci. Lett. 112: 99-103, 1990b.
146. MARTIN, J. L., MEINWALD, J., RADFORD, P., LIU Z., GARF, M. L. M., AND POHL, L. R.: Stereoselective metabolism of halothane enantiomers to trifluoroacetylated liver proteins. Drug Metab. Rev. 27: 179-189, 1995.
147. MCCARE, A. F., GALLAHER, E. J., WINTER, P. M., AND FIRESTONE, L. L.; Volatile anesthetic requirements difler in mice selectively bred for sensitivity or resistance to diazepam: implications for the site of anesthesia. Anesth. Analg. 76: 1313-1317, 1993.
148. MCDONALD, I.K., AND THORNTON, J. M.; Satisfying hydrogen bonding potential in proteins. J. Mol. Biol. 238: 777-793, 1994.
149. MILES, J. L., MOREY, E., CRAIN, F., GROSS, S., SAN JULIAN, J., AND CANADY, W. J.; Inhibition of α-chymotrypsin by diethyl ether and certain alcohols: a new type of competitive inhibition. J. Biol. Chem. 237: 1319-1322, 1962.
150. MILLER, K. W., PATON, W. D. M. SHITH, E. B., AND SMITH, R. A.; Physicochemical approaches to the mode of action of general anesthetics. Anesthesiology 36: 339-351, 1972.
151. MlLLER, K. W., REO, N. V., SCHOOT UITERKAMP, A. J. M., STENGLE, D. P., STENGLE, T. R., AND WILLIAMSON, K. L.; Xenon NMH: chemical shifts of a general anesthetic in common solvents, proteins, and membranes. Proc. Natl. Acad. Sci. USA 78: 4946-4949, 1981.
152. MILLER, K. W.; Molecular mechanisms by which general anaesthetics act. In Mechanisms of Drugs in Anaesthesia, ed. by S. A. Feldman, W. Paton. and C. Scurr, pp. 191-200, Hodder & Stoughton, Boston, 1993.
153. MILLHUSER, G. L., FIORI, W. R., AND MIICK, S. M.; Electron spin labels. Methods Enzymol. 246: 589-610, 1995.
154. MONERA, O. D., KAY, C. M., AND HODCES, R. S.; Protein donuturntion with guanidine hydrochloride or urea provides a different estimate of stability depending on the contributions of electrostatic interactions. Protein Sci. 3: 1984-1991, 1994.
155. A receptor complex. Brain Res. 615: 101-106, 1993.
156. MOORE, B., AND ROAF, H. E.; On certain physical and chemical properties of solutions of chloroform and other anaesthetics: A contribution to the chemistry of anaesthesia. Proc. R. Soc. Lond. B Biol. Sci. 77: 86-102, 1905.
157. MOORE, B., AND ROAF, H. E.; On certain physical and chemical properties of solutions of chloroform in water, saline, serum, and haemoglobin: a contribution to the chemistry of anaesthesia. Proc. R. Soc. Lond. B Biol. Sci. 73: 382-412, 1904.
158. MORGAN P. G., AND SEDENSKY, M. M.; Mutations conferring new patterns of sensitivitv to volatile Anesthrtics in Caennorhabditis elegans. Anesthesiology 81: 888-898, 1994.
159. MORTON, A., BAASE, W. A., AND MATTHEWS, B. W.; Energetic origins of ligand binding in an interior nonpolar cavity of T4 lysozyme. Biochemistry 34: 8564-8575, 1995.
160. MORTON, A., AND MATTHEWS, B. W.; Specificity of ligand binding in a buried nonpolar cavity of T4 lysozyme: linkage of dynamics and structural plasticity, Biochemistry 34: 8576-8578, 1995.
161. MULLER, N.; Search for realistic view of Hydrophobie effects, Acc, Chem. Res. 23: 23-28, 1990.
162. MURRAY-RUST, P., STALLINGS, W. C., MONTI, C. T., PRESTON, R. K., AND GLUSKER, J. P.; Intermolecular interactions of the C-F bond: the crystallographic environment of fluorinated carboxylic acids and related structures. J. Am. Chem. Soc. 106: 3206-3214, 1983.
163. NAKAGAWA, T., HAMANAKA, T., NISHIMURA, S., URUGA, T., AND KITO, Y.; The specific binding site or the volatile anesthetic diiodomethane to purple membrane by X-ray diffraction. J. Mol. Biol. 238: 297-301, 1994.
164. NUNES, A, C., AND SCHOENBORN, B. P.; Dichloromethane and myoglobin function. Mol. Phurmacol. 9: 835-839, 1973.
165. OLKKOLA, K. T., HAMUNEN, K., AND MAUNUKSELA, E-L., Clinical pharmacokinetics und pharmacodynamics of opiod analgesics in infants and children. (Clin. Pharmacokinet. 28: 385-404, 1995.
166. ÖSTERGREN, G.; Colchicine mitosis, chromosome contraction, narcosis and protein chain folding. Hereditas 30: 429-467, 1944.
167. PACE, C. N., SHIRLEY, B. A., MCNUTT, M., AND GAIIWALA, K.; Forces contributing to the conformational stability of proteins. FASEB J. 10: 75-83, 1996.
168. PAI, E. F., SACHSENHEIMER, W., SCHIRMER, R, H., AND SCHULZ, G. E.; Substrate positions and induced-fit in crystalline adonylate kinuse. J. Mol. Biol. 114: 37-45, 1977.
169. PFEIFFER, C. C.; Optical isomerism and pharmacological action, a generalization. Science (Wash. DC) 124: 29-31, 1956.
170. POCOCK, G., AND RICHARDS, C. D.; (Cellular mechanisms in general anaesthesia. Br. J. Anaesth. 66: 116-128, 1991.
171. POHORILLE, A., CIEPLAK, P., AND WILSON, M. A.; Interaction of anesthetics with the membrnne-water interface. Chem. Phys. 204: 337-345, 1996.
172. PRIVALOV, P. L., Stability of proteins: small globular proteins. Adv. Protein Chem. 33: 167-241, 1979.
173. QIN, Z., SZABO, G., AND CAFISO, D. S.; Anesthetics reduce the magnitude of the membrane dipole potential: measurements in lipid vesicles using voltagesensitive spin probes. Biochemistry 34: 5536-55411, 1995.
174. QUINLAN, J. J., FIRESTONE, S., AND FIRESTONE, L. L.; Isoflurane's enhancement of chloride flux through nit brain γ-aminobutyric acid type A receptors is stereoselective. Anesthesiology 83: 611-615, 1995.
175. RAFFA, R. B., AND PORRECA, F.; Thermodynamic analysis of the drug-receptor interaction. Life Sci. 44: 245-258, 1989.
176. RAINES, D. E., RANKIN, S. E., AND MILLER, K. W.: General anesthetics modify the kinetics of nicotinic ncetylcholine receptor desensitization at clinically relevant concentrations. Anesthesiology 82: 276-287, 1995.
177. RAMASUBBU, N., PARTHASARATHY, R., AND MURRAY-RUST, P.; Angular preferences of intormoleculnr forces around halogen centers: preferred directions of approach of electrophiles and nucleophiles around the carbon-halogen bond. J. Am. Chem. Soc. 108: 4308-4314, 1986.
178. KASHIN, A. A., IOFIN, M., AND HONIG, B.; Internal cavities and buried waters in globular proteins. Biochemistry 25: 3619-3625, 1986.
179. RASMUSSEN, B. F., STOCK, A. M., RINGE, D., AND PETSKO, G. A.; Crystalline ribonuclease A loses function below the dynamical transition at 220 K. Nature (Lond.) 357: 423-424, 1992.
180. RICHARDS, F. M., AND LIM, W. A.; An analysis of packing in the protein folding problem. Q. Rev. Biophys. 20: 423-498, 1994.
181. SACHSENHEIMER, W., PAI, E. F., SCHULZ, G. E., AND SCHIRMER, R. H.; Halothane binds in the adenine-specific niche of crystalline adenylate kinase. FEBS Lett. 79: 310-312, 1977.
182. SAVAGE, H. F. J., ELLIOT, C. J., FREEMAN, C. M., AND FINNEY, J. L.; Lost hydrogen bonds and buried surface area: rationalising stability in globular proteins. J. Chem. Soc. Faraday Trans. 89: 2609-2617, 1993.
183. SCHARF, D., KLEIN, M. L., AND ECKENHOFF, R. G.; Halothane solvation - can it form hydrogen bonds? Assoc. Univ. Anesth. 43: A68, 1996.
184. SCHARF, D., AND LAASONEN, K.; Structure, effective pair potential and properties of halothane. Chem. Phys. Lett. 258: 276-282, 1996.
185. SCHOENBORN, B. P.; Binding of cyclopropane to sperm whale myoglobin, Nature (Lond.) 214: 1120-1122, 1967.
186. SCHOENBORN, B. P.; Binding of xenon to horse haemoglobin. Nature (lond.) 208: 760-762, 1965.
187. SCHOENBORN, R. P.; Dichloromethane as an antisickling agent in sickle cell hemoglobin. Proc. Nutl. Acad. Sci. USA 73: 4195-4199, 1976.
188. SCHOENBORN, B. P., WATSON, H. C., AND KENDREW, J. C.; Binding of xenon to sperm whale myoglobin. Nature (Lond.) 207: 28-30, 1965.
189. SEDENSKY, M. M., CASCORBI, H. F., MEINWALD, J., RADFORD, P., AND MORGAN, P. G.; Genetic differences affecting the potency of stereoisomers of halothane. Proc. Natl. Acad. Sci. USA 91: 10054-10058, 1994.
190. SHANKS, C. A.; Pharmacokinetics of the nondepolarizing neuromuscular relaxants applied to the calculation of bolus and infusion dosage regimens. Anesthesiology 64: 72-86, 1986.
191. SHIBATA, A., MORITA, K., YAMASHITA, T., KAMAYA, H., AND UEDA, I.; Anestheticprotein interaction: effects of volatile anesthetics on the secondary structure of poly(L-lysine). J. Pharm. Sci. 80: 1037-1041, 1991.
192. SHIRLEY, B. A., STANSSENS, P., HAHN, U., AND PACE, C. N.: Contribution of hydrogen bonding to the conformational stability of ribonuclease T1. Biochemistry 31: 725-732, 1992.
193. SHRAKE, A., AND Ross, P. D.; Biphasic denaturaition of human albumin due to ligand redistribution during unfolding. J. Biol. Chem. 263: 15392-15399, 1988.
194. SINGER S. J., AND NICOLSON, G. L.; The fluid mosaic model of the structure of cell membranes. Science (Wash. DC) 175: 720-731, 1972.
195. SKLAR, L. A.; Real-time spectroscopic analysis of ligand-receptor dynamic Annu. Rev. Biophys. Biophys. Chem. 16: 479-506, 1987.
196. STURTEVANT, J. M.; Biochemical applications of differential scanning calorimetry. Annu. Rev. Phys. Chem. 38: 463-488, 1987.
197. SVERGUN, D. I., BARBERATO, C., KOCH, M. H. J., FETLER, L., AND VACHETTE, P.; Large differences are observed between the crystal and solution quarternary structures of allosteric aspartate transcarbamylase in the R state. Proteins 27: 110-117, 1997.
198. TAHERI, S., HALSEY, M. J., LIU, J., EGER, E. I., KOBLIN, D. D., AND LASTER, M. J.; What solvent host represents the site of action of inhaled anesthetics in humans, rats, and dogs? Anesth. Analg. 72: 627-634, 1991.
199. TANFORD, C.; The Hydrophobic Effect: Formation of Micelles and Biological Membranes, p. 200, John Wiley & Sons. New York. 1973.
200. TANNER, J. W., ECKENHOFF, R. G., AND LIEBMAN, P. A.; Protein stabilization by an inhalntional anesthetic. Biophys. J. 72: A417, 1997.
201. TARG, A. G., YASUDA, N., EGER, E. I., HUANG, G., VERNICE, G. G., TERRELL, R. C., AND KOSLIN D. D.; Halogonation and anesthetic potency. Anesth. Analg 68: 599-602, 1989
202. TEGONI, M., RAMONI, R., BIGNETTI, E., SPINELLI, S., AND CAMBILLAU, C.; Domain swapping creates a third putative combining site in bovine odorant binding protein dimer. Nat. Struct. Biol. 3: 863-867, 1996.
203. TESTA, B., JENNER, P., KILPATRICK, G. J., EL TAYAR, N., VAN DE WATERBEEMD, H., AND MARSDEN, C. D.; Do thormodynamic studies provide information on both the binding to and the activation of dopaminergic and other receptors? Biochem. Pharmacol. 36: 4041-4046, 1987.
204. TILTON, R. F., DEWAN, J. W., AND PETSKO, G. A.; Effects of temperature on protein structure and dynamics: X-ray cristallographic studies of the protein ribonuclease-A at nine different temperatures from 98 to 320 K. Biochemistry 31: 2469-2481, 1992.
205. TILTON, R. F., KUNTZ, I. D., AND PETSKO, G. A.; Cavities in proteins: structure of a metmyoglobin-xenon complex solved to 1.9 Á. Biochemistry 23: 2849-2857, 1984.
206. TILTON, R. F., SINGH, U. C., KUNTZ, I. D., AND KOLLMAN, P. A.; Protein- ligand dynamics: a 96 picosecond simulation of a myoglobin-xenon complex. J. Mol. Biol 199: 195-211, 1988.
207. TRUDELL, J. R.: Role of membrane fluidity in anesthetic action. In Drug and Anesthetic Effects on Membrane Structure and Function, ed. by R. C. Aloia, C. C. Curtain, and L. M. Gordon, pp. 1-14, Wiley-Liss, New York, 1991.
208. TRUDELL, J. R., AND HUBBELL, W. L.; Localisation of molecular halothane in phospholipid bilayer model nerve membranes. Anesthesiology 44: 202-205, 1976.
209. TUCKERMAN, M. E., UNGAR, J. P., VON ROSENVINGE, T., AND KLEIN, M. L.; Ab initio molecular dynamics simulations. J. Phys. Chcm. 100: 12878-12887, 1996.
210. UEDA, L.; Interfacial effects of anesthetics on membrane fluidity. In Drug and Anesthetic Effects on Membrane Structure and Function, ed. by R. C. Aloia, C. C, Curtain, and L. M. Gordon, pp. 15-33, Wiley-Liss, New York, 1991.
211. UEDA, L, AND KAMAYA, H.; Kinetic and thermodynamic aspects of the mechanism of general anesthesia in a model system of firefly luminescence in vitro, Anesthesiology 38: 425-436, 1973.
212. UEDA, L, AND YAMANAKA, M.; Titration calorimetry of anesthetic-protein interaction: negative enthalpy of binding and anesthetic potency. Biophys. J. 72: 1812-1817, 1997.
213. UNWIN, N.; Acetylcholine receptor channel imaged in the open state. Nature (Lond.) 373: 37-43, 1995.
214. URBANOVA, M. DUKOR, R. K., PANCOSKA, P., GUPTA, V. P., AND KEIDERLING, T. A.; Comparison of α-lactalbumin and lysozyme using vibrational circular dichroism: evidence for a difference in crystal and solution structures. Biochemistry 30: 10479-10485, 1991.
215. VANDERKOOI, J. M., LANDESBERG, R., SELICK, H., AND MCDONALD, G. G.; Interaction of general anesthetics with phospholipid vesicles and biological membranes. Biochim. Biophys. Acta 464: 1-16, 1977.
216. VERSCHUEREN, K. H. G., SELIÉE, F., ROZEBOOM, H. J., KALK, K. H., AND DIJKSTRA, B. W.; Crystallographic analysis of the catalytic mechanism of haloalkane dehalogenase. Nature (Lond.) 383: 693-698, 1993.
217. VIGUERA, A. R., AND SERRANO, L.; Side-chain interactions between sulfurcontaining amino acids and phenylalanine in α-helices. Biochemistry 34: 8771-8779, 1995.
218. WANN, K. T., AND. MACDONALD, A, G.; Actions and interactions of high pressure and general anaesthetics. Prog. Neurobiol. 30: 271-307, 1988.
219. WEBER, G., AND DRICKAMER, H. G.; The effect of high pressure upon proteins and other biomolocules. Q. Rev. Biophys. 16: 89-112, 1983.
220. WEILAND, G. A., AND MOLINOFF, P. B.; Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties. Life Sci. 29: 313-330, 1981.
221. 2 equilibrium in vitro. Anesthesiology 38: 579-581, 1971.
222. WILLIAMS, D. E., AND JAN, J.; Point-charge models of molecules derived from least squares fitting of the electric potential. Adv. At. Mol. Opt. Phys 23: 87-129, 1987.
223. WOOD. S. C., TONNER, P. H., DE ARMENDI, A. A., BUGGE, B., AND MILLER, K. W.; Channel inhibition by alkanols occurs at a binding site on the nicotinic acetyleholine receptor. Mol. Pharmacol. 47: 121-130. 1995.
224. WÜTHRICH, K.; NMR: this other method for protein and nucleic acid structure determination. Acta Crystallogr. D51: 249-270. 1995.
225. 19F NMR spectroscopv to studies on intact tissues. Bull. Magn. Reson. 12: 209-217, 1991.
226. 19F NMR spectroscopy. FEBS Lett. 162: 334-338, 1983.
227. WYRWICZ, A. M., PSZENNY, M. H., SCHOFIELD, J. C., TILIMAN, P. C., GORDON, R. E., AND MARTIN, P. A.; Noninvasive observations of fluorinnted anesthetics in rabbit brain by fluorine 19 nuclear magnetic resonance. Science (Wash. DC) 222: 428-430, 1983b.
228. 129Xe-[lH] intermolecular nuclear Overhausor effects. Biochim. Biophys. Acta 1323: 154-162, 1997.
229. 19F nuclear magnetic resonance investigation of stereoselective binding of isofiurane to bovine serum albumin. Biophys. J. 70: 532-538, 1996.
230. 19F-NMR imaging and apectroscopy of sevoflurnne uptake, distribution, and elimination in rat brain. Anesthesiology 83: 766-774, 1995.